Meeting
2016 ASCO Annual Meeting
A randomized phase 2 study of abemaciclib versus docetaxel in patients with stage IV squamous cell lung cancer (SqCLC) previously treated with platinum-based chemotherapy.
Authors
Giorgio V. Scagliotti
University of Torino, Torino, Italy
Giorgio V. Scagliotti , Ramaswamy Govindan , Karla Hurt , Alan Chiang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Clinical Trial Registration Number
NCT02450539
Citation
J Clin Oncol 34, 2016 (suppl; abstr TPS9101)
DOI
10.1200/JCO.2016.34.15_suppl.TPS9101
Abstract #
TPS9101
Poster Bd #
423a
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
A randomized phase 2 study of abemaciclib versus docetaxel in patients with stage IV squamous non-small cell lung cancer (sqNSCLC) previously treated with platinum-based chemotherapy.
First Author: Giorgio V. Scagliotti
Poster
2017 ASCO Annual Meeting
Phase II study of the FGFR inhibitor AZD4547 in previously treated patients with FGF pathway-activated stage IV squamous cell lung cancer (SqNSCLC): LUNG-MAP sub-study SWOG S1400D.
First Author: Charu Aggarwal
Poster
2017 ASCO Annual Meeting
A phase II study of GDC-0032 (taselisib) for previously treated PI3K positive patients with stage IV squamous cell lung cancer (SqNSCLC): LUNG-MAP sub-study SWOG S1400B.
First Author: James Lloyd Wade III
Poster
2011 ASCO Annual Meeting
A single-arm phase II trial evaluating docetaxel, vinorelbine, and GM-CSF in stage IV melanoma.
First Author: J. P. Fruehauf